北京依格斯Excel PharmaStudies www.excel-china.com
依格斯(北京)医疗科技有限公司成立于1999年，是中国最早的临床研究合同研究组织(CRO)公司之一。作为中国领先的CRO，依格斯提供与药品临床开发相关的一系列专业服务，包括产品注册、一期至四期临床试验、生物等效性试验和国际多中心临床试验的监查、项目管理、受试者

招募、数据管理、生物统计、翻译、医学报告撰写、市场调研和产品开发战略咨询等。 
公司总部位于北京，在上海、广州、南京、成都、重庆、沈阳、南宁、武汉、西安、哈尔滨等城市设有办事处或服务网点。在美国加州的旧金山设有分公司并计划近期在欧洲开设分公司。 
目前，依格斯拥有100名优秀的员工，是中国国内规模最大

的提供临床研究服务的CRO公司。预计到2008年年底，员工人数将达250人。 
依格斯依靠严谨勤奋的工作态度、客户至上的精神、适中的价格赢得了客户的广泛信任和业内良好的口碑。
PPD收购依格斯医疗科技 

Excel, a leading CRO in China, was founded in Beijing in 1999, and in the last eight years it has grown into a full service CRO providing comprehensive regulatory, clinical research and quality assurance services in the areas of clinical drug development, Phase I~IV, bioequivalence studies, clinical monitoring, project management, patient recruitment, data management, biostatistics analysis, translation, medical report writing and other related services.
Excel's headquarters is located in Beijing, and there are seven satellite offices located throughout China in Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, Shenyang and Wuhan. Excel has established business offices in the US (San Francisco) and Europe (Cologne, Germany), and has created partnerships with companies in Korea, Taiwan and Australia.
Excel has successfully conducted over 125 clinical trials (phase I to IV) and has obtained nearly 200 regulatory approvals. As one of the few CROs in China using Oracle and SAS for clinical data management and biostatistics analysis, our biometrics services are being developed to comply with US FDA 21 CFR Part 11 requirements.
Our clients currently include many of the top international pharmaceutical companies and many leading biotech companies.